CATTANEO, ANTONINO
 Distribuzione geografica
Continente #
NA - Nord America 31.900
EU - Europa 24.649
AS - Asia 16.662
SA - Sud America 2.097
AF - Africa 206
Continente sconosciuto - Info sul continente non disponibili 99
OC - Oceania 39
Totale 75.652
Nazione #
US - Stati Uniti d'America 31.497
IT - Italia 7.740
CN - Cina 4.980
SG - Singapore 4.845
SE - Svezia 3.944
IE - Irlanda 3.218
KR - Corea 2.879
RU - Federazione Russa 2.532
DE - Germania 1.917
BR - Brasile 1.852
TR - Turchia 1.775
UA - Ucraina 1.534
GB - Regno Unito 1.124
HK - Hong Kong 888
FI - Finlandia 700
NL - Olanda 497
CH - Svizzera 413
VN - Vietnam 363
AT - Austria 312
CA - Canada 237
FR - Francia 155
IN - India 154
JP - Giappone 146
BE - Belgio 131
PL - Polonia 116
MX - Messico 107
ES - Italia 102
IL - Israele 96
EU - Europa 92
ID - Indonesia 88
BD - Bangladesh 86
AR - Argentina 84
ZA - Sudafrica 79
IQ - Iraq 50
AE - Emirati Arabi Uniti 42
VE - Venezuela 41
PK - Pakistan 40
EC - Ecuador 37
LT - Lituania 33
AU - Australia 29
UZ - Uzbekistan 28
MA - Marocco 26
JO - Giordania 25
KE - Kenya 24
AL - Albania 22
CO - Colombia 21
RO - Romania 21
SA - Arabia Saudita 20
CL - Cile 19
CZ - Repubblica Ceca 17
DZ - Algeria 15
BG - Bulgaria 14
PE - Perù 14
TW - Taiwan 14
AZ - Azerbaigian 13
DK - Danimarca 13
PH - Filippine 13
RS - Serbia 13
EG - Egitto 12
PY - Paraguay 12
HU - Ungheria 11
IR - Iran 11
NO - Norvegia 11
NP - Nepal 10
PS - Palestinian Territory 10
UY - Uruguay 10
OM - Oman 9
TN - Tunisia 9
GR - Grecia 8
JM - Giamaica 8
KZ - Kazakistan 8
LB - Libano 8
LU - Lussemburgo 8
NZ - Nuova Zelanda 8
TT - Trinidad e Tobago 8
DO - Repubblica Dominicana 7
BN - Brunei Darussalam 6
GE - Georgia 6
HN - Honduras 6
KG - Kirghizistan 6
PA - Panama 6
ET - Etiopia 5
KW - Kuwait 5
NI - Nicaragua 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
TH - Thailandia 5
AM - Armenia 4
AO - Angola 4
BO - Bolivia 4
CR - Costa Rica 4
HR - Croazia 4
LK - Sri Lanka 4
MT - Malta 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BH - Bahrain 3
GA - Gabon 3
Totale 75.563
Città #
Pisa 5.752
Dallas 3.705
Jacksonville 3.409
Chandler 3.259
Dublin 3.212
Seoul 2.870
Ashburn 2.806
Boardman 2.154
Singapore 2.146
Wilmington 1.356
Izmir 1.303
Hefei 1.050
Ann Arbor 928
Hong Kong 867
Moscow 818
Boston 773
Beijing 743
Millbury 681
New York 598
Düsseldorf 529
The Dalles 522
Kent 495
San Mateo 462
Los Angeles 422
Istanbul 416
Amsterdam 407
Bern 367
Mestre 367
Bremen 320
Lawrence 314
Seattle 311
Munich 303
Ogden 295
Vienna 291
Woodbridge 235
Princeton 204
Washington 184
Scuola 177
São Paulo 175
Dearborn 172
Saint Petersburg 167
Chicago 163
Dong Ket 163
Helsinki 156
Milan 155
Guangzhou 154
Santa Clara 150
Brussels 125
Buffalo 124
Tokyo 123
Shanghai 122
Council Bluffs 115
Rome 114
San Paolo di Civitate 114
Columbus 112
Warsaw 104
Turku 95
North Bergen 92
Brooklyn 90
Montreal 87
Wuhan 82
Fairfield 81
Atlanta 79
Toronto 79
Jakarta 78
Stockholm 74
Houston 73
Holon 70
London 70
Orem 69
Frankfurt am Main 65
Ho Chi Minh City 65
Denver 63
Norwalk 60
Nanjing 56
Chennai 55
Johannesburg 55
San Giuliano Terme 51
Las Vegas 49
Belo Horizonte 45
Hanoi 45
Rio de Janeiro 45
Kunming 43
San Francisco 43
Andover 42
Mexico City 42
Phoenix 42
Falls Church 39
Berlin 38
Manchester 35
Poplar 35
Brasília 34
Cambridge 34
Changsha 34
Shenzhen 34
Bientina 33
Salt Lake City 33
Zhengzhou 33
Curitiba 32
Jiaxing 32
Totale 49.990
Nome #
Initial events leading to ß amyloid expression in anti-NGF transgenic mice. 2.613
A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration 1.151
A quantitative bioassay to determine the inhibitory potency of NGF-TrkA antagonists 1.052
The contribution of early inflammation to neurodegeneration in anti-Nerve Growth Factor mice 332
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 304
(2008) Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-ß-Mediated Cortical Synaptic Dysfunction 304
A new intramolecular biosensor reveals Tau conformational changes in pathological conditions 297
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 282
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 279
Precursor and mature NGF live tracking: one versus many at a time in the axons 278
Activity-dependent expression of Channelrhodopsin at neuronal synapses 275
Site-specific labeling of neurotrophins and their receptors via short and versatile peptide tags 272
Ligand signature in the membrane dynamics of single TrkA receptor molecules 262
Assessment of antibody library diversity through next generation sequencing and technical error compensation 261
A functional domain on the aloha-latrotoxin molecule, distinct from the binding site, involved in cathecolamine secretion from PC12 cells: identification with monoclonal antibodies 257
Corrigendum: Precursor and mature NGF live tracking: one versus many at a time in the axons 257
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 255
Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate 251
A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 246
A protein silencing switch by ligand-induced proteasome targeting intrabodies 246
NGF steers microglia toward a neuroprotective phenotype 242
A new generation of non invasive NGF-based therapies for Alzheimer’s Disease 241
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 241
Alpha-synuclein fret biosensors reveal early alpha-synuclein aggregation in the endoplasmic reticulum 241
A recombinant cell line expressing a form of the Y13-259 anti-p21ras antibody which binds protein A and may be produced as ascites 240
A new mechanism for Alzheimer Neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 237
A non-radioactive in situ hybridization method that does not require RNAse-free conditions 237
Fast-diffusing p75NTR monomers support apoptosis and growth cone collapse by neurotrophin ligands 236
Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice 235
Site-specific biotinylation of neurotrophins and their receptors by the insertion of short versatile peptide tags 234
Alzheimer-like neurodegeneration in anti-Nerve Growth Factor transgenic mice 233
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 233
'Phytoantibodies': a general vector for the expression of immunoglobulin domains in transgenic plants 232
Fluorolabeling of the PPTase-Related Chemical Tags: Comparative Study of Different Membrane Receptors and Different Fluorophores in the Labeling Reactions 232
A new generation of NGF-based therapy for Alzheimer’s disease 231
Ligand-induced dynamics of neurotrophin receptors investigated by single-molecule imaging approaches 230
Single molecule tracking and spectroscopy unveils molecular details in function and interactions of membrane receptors 230
An Optimized Procedure for the Site-Directed Labeling of NGF and proNGF for Imaging Purposes 228
A small molecule targeting the multifactorial nature of Alzheimer's disease 228
A critical period in the sensitivity of basal forebrain cholinergic neurones to NGF deprivation 227
Ligand Fingerprinting in the Membrane Dynamics of Single TrkA and P75NTR Neurotrophin Receptors 223
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 220
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 218
Purification and proteomic profiling of PSD-95 intereactors at in vivo potentiated synapses 217
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 217
Single Molecule Imaging and Tracking of Neurotrophins and their Receptors in Living Neuronal Cells 216
A triheptanoin-supplemented diet rescues hippocampal hyperexcitability and seizure susceptibility in FoxG1+/− mice 215
Mapping potentiated synapses in the hippocampus during acquisition and consolidation of a contextual fear memory 214
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 213
A macromolecular structure favouring microtubule assembly in NGF-differentiated pheochromocytoma cells (PC12) 211
Nerve growth factor derivative NGF61/100 promotes outgrowth of primary sensory neurons with reduced signs of nociceptive sensitization 208
IGF-1 Restores Visual Cortex Plasticity in Adult Life by Reducing Local GABA Levels 207
Single particle tracking of acyl carrier protein (ACP)-tagged TrkA receptors in PC12nnr5 cells 207
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 206
Post-translational selective intracellular silencing of acetylated proteins with de novo selected intrabodies 206
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 205
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 204
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 204
Conformational Rigidity within Plasticity Promotes Differential Target Recognition of Nerve Growth Factor 204
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 202
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice 202
A humanized anti-NGF antibody with analgesic properties 201
Abeta (1-42) impairs LTP in mous eneocortex through RAGE mediated activation of p38 MAP kinase 200
The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells 200
Large differences in aging phenotype between strains of the short-lived annual fish Nothobranchius furzeri 199
Tau Modulates VGluT1 Expression 199
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 196
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 193
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 193
Alzheimer-like neurodegeneration in aged anti-Nerve Growth Factor (NGF) mice 191
Site-specific direct labeling of neurotrophins and their receptors: From biochemistry to advanced imaging applications 191
Abeta-Dependent Inhibition of LTP in Different Intra-Cortical Circuits of the Visual Cortex: The role of RAGE 190
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 190
The conundrum of the high-affinity NGF binding site formation unveiled? 190
A continuous model of physiological prion aggregation suggests a role for Orb2 in gating long-term synaptic information 190
Antibodies to nerve growth factor (NGF) prolong the sensitive period for monocular deprivation in the rat 189
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 189
Gene Expression of Disease-related Genes in Alzheimer's Disease is Impaired by Tau Aggregation 189
Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells 186
An unbalance of proNGF/NGF signalling determines AD-like neurodegeneration in mice. 186
Identification of an ERK Inhibitor as a Therapeutic Drug Against Tau Aggregation in a New Cell-Based Assay 184
A microglial function for the nerve growth factor : predictions of the unpredictable 183
TANEZUMAB, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain 183
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 183
proNGF/NGF mixtures induce gene expression changes in PC12 cells that neither singly produces 183
RACK1 Is a Ribosome Scaffold Protein for beta-actin mRNA/ZBP1 Complex 182
Temperature affects longevity and age-related locomotor and cognitive decay in the short-lived fish Nothobranchius furzeri 182
Role of NGF in modulating adult neurogenesis in ALzheimer's disease mouse model 182
Structural and functional properties of mouse proNGF 181
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 180
PISA screening protocol – A protocol for the selection of intracellular antibodies against post-translational modifications of native proteins 180
Human TrkAR649W mutation impairs nociception, sweating and cognitive abilities : a mouse model of HSAN IV 179
Cortical Seizures in FoxG1 +/− mice are accompanied by akt/s6 overactivation, excitation/inhibition imbalance and impaired synaptic transmission 179
Effects of cholinesterase inhibitor galantamine in a mouse model of Alzheimer disease, the anti-NGF AD11 mice 178
Amelioration of the neurodegenerative phenotype in AD11 anti-NGF mice 177
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology 177
NGF and proNGF Reciprocal Interference in Immunoassays: Open Questions, Criticalities, and Ways Forward 176
Neuroantibodies: ectopic expression of a recombinant anti-substance P antibody in the central nervous system of transgenic mice 175
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 175
ProNGF Is a Cell-Type-Specific Mitogen for Adult Hippocampal and for Induced Neural Stem Cells 175
Totale 25.837
Categoria #
all - tutte 338.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 338.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.005 0 0 0 0 0 517 307 490 501 1.146 347 697
2021/20223.691 387 30 40 241 245 67 82 336 247 203 126 1.687
2022/202315.413 1.024 827 600 1.087 925 1.530 9 3.998 4.737 91 241 344
2023/20244.857 793 128 507 144 283 990 186 200 599 170 36 821
2024/202519.229 2.304 385 657 1.976 2.130 320 1.472 807 2.985 841 2.519 2.833
2025/202616.730 2.301 3.258 4.899 3.489 2.295 488 0 0 0 0 0 0
Totale 76.345